Radiation-Induced Vaccination to Breast Cancer
Annual rept. 30 Sep 2013-29 Sep 2014
CALIFORNIA UNIV LOS ANGELES
Pagination or Media Count:
The purpose of this study is to combine the TGFbeta neutralizing antibody, Fresolimumab, with Radiation Therapy RT to treat metastatic breast cancer. This is based on the rationale that RT can be limited to 1 or 2 lesions which in turn serve as antigenic reservoirs that drive abscopal effects. Patients receive either 1mg or 10mg of the anti-TGFbeta antibody.
- Medicine and Medical Research